Evidence map›Paper›PMID 42142096›Full record

ArticleJACC. Asia2026

Impact of Angiography-Derived Physiological Patterns of CAD and Optimal Hemodynamics Post-PCI on Residual Angina.

Kotaro Miyashita, Yoshinobu Onuma, Emiliano Bianchini, Takashi Muramatsu, Gaku Nakazawa, Yuki Ishibashi, Ken Kozuma, Taku Asano, Yuki Katagiri, Takayuki Okamura and 14 more

Registry-linked trialAbstract read
In one paragraph

Article in JACC. Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05117866 (A Multicenter, Single Arm, Open-label Trial of Prasugrel Monotherapy After PCI With the SYNERGY® Stent in Patients With Chronic Coronary Syndrome or Non-ST-elevation Acute Coronary Syndromes), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05117866 naactive not recruitingnot on this map

A Multicenter, Single Arm, Open-label Trial of Prasugrel Monotherapy After PCI With the SYNERGY® Stent in Patients With Chronic Coronary Syndrome or Non-ST-elevation Acute Coronary Syndromes

TypeinterventionalSponsorMeditrix CorpRan2020 to 2025Enrolled307ConditionsChronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary SyndromeArmsprasugrel Monotherapy
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Kotaro MiyashitaDepartment of Cardiology, University of Galway, Galway, Ireland; CORRIB Research Centre for Advanced Imaging and Core Lab, University of Galway, Galway, Ireland; Department of Cardiology, Ageo Central General Hospital, Ageo, Japan.
Yoshinobu OnumaDepartment of Cardiology, University of Galway, Galway, Ireland; CORRIB Research Centre for Advanced Imaging and Core Lab, University of Galway, Galway, Ireland. Electronic address: yoshinobuonuma@gmail.com.
Emiliano BianchiniDepartment of Cardiology, University of Galway, Galway, Ireland; CORRIB Research Centre for Advanced Imaging and Core Lab, University of Galway, Galway, Ireland.
Takashi MuramatsuDepartment of Cardiology, Fujita Health University Hospital, Toyoake, Japan.
Gaku NakazawaDepartment of Cardiology, Kindai University, Osaka, Japan.
Yuki IshibashiDepartment of Cardiology, School of Medicine, St. Marianna University, Kawasaki, Japan.
Ken KozumaDepartment of Cardiology, Teikyo University Hospital, Tokyo, Japan.
Taku AsanoDepartment of Cardiology, St. Luke International Hospital, Tokyo, Japan.
Yuki KatagiriDepartment of Cardiology, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
Takayuki OkamuraDivision of Cardiology, Department of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.
Yoshihiro MorinoDivision of Cardiology, Iwate Medical University, Iwate, Japan.
Norihiro KogameDepartment of Cardiology, Tokyo Rosai Hospital, Tokyo, Japan.
Masafumi OnoDepartment of Cardiology, St. Luke International Hospital, Tokyo, Japan.
Yosuke MiyazakiDivision of Cardiology, Department of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.
Shimpei NakataniDepartment of Cardiology, JCHO Hoshigaoka Medical Center, Osaka, Japan.
Masato NakamuraDivision of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
Akihiro TobeDepartment of Cardiology, University of Galway, Galway, Ireland; CORRIB Research Centre for Advanced Imaging and Core Lab, University of Galway, Galway, Ireland.
Asahi OshimaDepartment of Cardiology, University of Galway, Galway, Ireland; CORRIB Research Centre for Advanced Imaging and Core Lab, University of Galway, Galway, Ireland.
Tsung-Ying TsaiDepartment of Cardiology, University of Galway, Galway, Ireland; CORRIB Research Centre for Advanced Imaging and Core Lab, University of Galway, Galway, Ireland.
Scot GargDepartment of Cardiology, Royal Blackburn Hospital, Blackburn, United Kingdom; School of Medicine, University of Central Lancashire, Preston, United Kingdom.
Kengo TanabeDivision of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan.
Yukio OzakiDepartment of Cardiology, Fujita Health University Okazaki Medical Center, Aichi, Japan.
John A SpertusUniversity of Missouri-Kansas City's Healthcare Institute for Innovations in Quality and Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.
Patrick W SerruysDepartment of Cardiology, University of Galway, Galway, Ireland; CORRIB Research Centre for Advanced Imaging and Core Lab, University of Galway, Galway, Ireland. Electronic address: patrick.w.j.c.serruys@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFocal stenotic coronary lesions, as defined by the invasive pullback pressure gradient index (PPGI) measured before percutaneous coronary intervention (PCI), are associated with less residual angina than diffuse lesions as assessed by the Seattle Angina Questionnaire (SAQ).

objectivesThis study aims to investigate the interaction between a lesion's baseline functional phenotype (focal vs diffuse) and the physiological success of PCI, as defined by a post-procedural Murray-based angiography-derived flow ratio (μFR) above 0.90 (adequacy of flow [AOF]), in correlation with angina status at 2 years.

methodsThe ASET-Japan study enrolled 203 patients with chronic coronary syndrome. The baseline functional disease pattern and the achievement of AOF (post-PCI μFR > 0.90) were analyzed as potential factors influencing the rate of residual angina at 2 years.

resultsSAQ scores were obtained in 186 patients. The median follow-up duration was 771 days (Q1-Q3: 752-805). AOF was achieved in in 61.3% (114 of 186; 95% CI: 54.1-68.0), with the μFR post-PCI differing significantly by the lesion's baseline phenotype (diffuse 0.92 ± 0.06 vs focal 0.94 ± 0.04; P < 0.001). At 2-year follow-up, patients in the AOF group with preprocedural focal vs diffuse disease had significantly better angina frequency scores (99.2 ± 3.3 vs 94.8 ± 11.7; P = 0.007), and less frequent residual angina (6.7%; 4 of 60; 95% CI: 2.6-16.2 vs 22.0%; 11 of 50; 95% CI: 12.5-34.9; P = 0.040).

conclusionsIn patients who achieve AOF during PCI, the baseline functional phenotype of treated lesions in patients with or without angina at follow-up is significantly different. A global physiological assessment integrating AOF and the baseline functional pattern of disease is potentially useful to accurately predict residual angina post-PCI. (Acetyl Salicylic Elimination Trial Japan: The ASET Japan Pilot Study [ASET-JAPAN], NCT05117866).

Indexed as

completeness of revascularizationcoronary artery diseaseMurray law-based quantitative flow ratiopullback pressure gradient indexquantitative flow ratio

Identifiers

PMID42142096
PMCPMC13350794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.